Skip to main content
Fagron N.V. logo

Fagron N.V. — Investor Relations & Filings

Ticker · FAGR ISIN · BE0003874915 LEI · 549300TRKRUFK2RRG779 BR Manufacturing
Open in API
Filings indexed 1,979 across all filing types
Latest filing 2026-04-16 Major Shareholding Noti…
Country BE Belgium
Listing BR FAGR

About Fagron N.V.

https://fagron.com/

Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.

Recent filings

Filing Released Lang Actions
260416_Fagron transparency notifications Blackrock NL.pdf
Major Shareholding Notification Classification · 92% confidence The document is a press release titled “Openbaarmaking van transparantiekennisgevingen van BlackRock, Inc.” under Belgian law, detailing BlackRock’s crossing above and below the 3% ownership threshold in Fagron and providing precise share and instrument counts. This clearly matches notifications of significant shareholding changes (threshold crossings). Therefore, it is a Major Shareholding Notification (Code: MRQ).
2026-04-16 Dutch
Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a press release inviting shareholders to the Ordinary and Extraordinary General Meetings (AGM and EGM), providing the agenda, proposed resolutions, and instructions for registration and voting. It is sent to shareholders to provide information ahead of the meetings and to solicit their votes. Therefore, it fits the Proxy Solicitation & Information Statement category.
2026-04-10 Dutch
Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026
Report Publication Announcement Classification · 56% confidence The document is a short press release (2,701 characters) announcing the convening of an Ordinary and Extraordinary General Meeting and stating that the formal convening notice, agenda and explanatory notes are available on the company website. It does not itself contain the full agenda or voting materials, but merely announces their publication and availability. Under the “Menu vs Meal” rule, this is an announcement of publication rather than the full information statement. Therefore, it best fits the Report Publication Announcement category (RPA).
2026-04-10 English
Board of Directors report related to authorised capital.pdf
Proxy Solicitation & Information Statement Classification · 82% confidence The document is a “Special Report of the Board of Directors” prepared under Belgian Company Code Article 7:199 to support a resolution at an extraordinary general meeting, detailing and explaining the proposed renewal of the board’s authorization to increase the Company’s authorised capital and amendments to the articles of association. It is not an annual or audit report, nor a simple announcement of publication, but rather contains detailed explanatory material sent to shareholders to inform and solicit their votes on the capital authorization at a shareholders’ meeting. This aligns with a Proxy Solicitation & Information Statement, which provides meeting materials and voting information to shareholders.
2026-04-10 English
Raad van Bestuur verslag inzake toegestane kapitaal.pdf
Share Issue/Capital Change Classification · 85% confidence The document is a detailed “bijzonder verslag” (special report) prepared by the board of Fagron NV under Belgian law (article 7:199 WVV) to support a proposed renewal of the board’s authorization to increase the company’s capital (authorized capital). It outlines background, purposes, and terms of the capital-authorization resolution to be voted at an extraordinary general meeting. This is not an Earnings Release, Annual Report, proxy of general governance, or simple announcement; it directly concerns a capital change/authorized capital proposal. Under the classification scheme, it best fits “Share Issue/Capital Change” (SHA).
2026-04-10 Dutch
11 May 2026 - EGM - Fagron NV Board of Directors report related to authorised capital.pdf
Proxy Solicitation & Information Statement Classification · 82% confidence The document is a special report of the board of directors prepared under Belgian company law (Article 7:199 BCCA) in connection with an Extraordinary General Meeting to renew the board’s authorised capital. It is not an annual or interim financial report nor an earnings release, nor is it simply an announcement of publication. Instead, it provides detailed background, legal basis, and proposals for shareholder approval, which aligns with materials sent to shareholders to solicit votes at a general meeting (i.e., a proxy statement). Therefore, the correct classification is Proxy Solicitation & Information Statement (PSI).
2026-04-10 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.